James B. Tananbaum's Net Worth

$396 Million

Estimate Recalculated Feb 27, 2024 05:40PM EST

Who is James B. Tananbaum?

James B. Tananbaum has an estimated net worth of $396 Million. This is based on reported shares across multiple companies, which include PARDES BIOSCIENCES, INC., Intellia Therapeutics, Inc., 10x Genomics, Inc., Aclaris Therapeutics, Inc., Quantum-Si Inc, AERIE PHARMACEUTICALS INC, Kinnate Biopharma Inc., Gemini Therapeutics, Inc. /DE, Aimmune Therapeutics, Inc., Theseus Pharmaceuticals, Inc., and AMBIT BIOSCIENCES CORP.

SEC CIK

James B. Tananbaum's CIK is 0001581754

Past Insider Trading and Trends

2019 was James B. Tananbaum's most active year for acquiring shares with 25 total transactions. James B. Tananbaum's most active month to acquire stocks was the month of July. 2020 was James B. Tananbaum's most active year for disposing of shares, totalling 32 transactions. James B. Tananbaum's most active month to dispose stocks was the month of November. 2021 saw James B. Tananbaum paying a total of $59,275,696.26 for 32,455,160 shares, this is the most they've acquired in one year. In 2020 James B. Tananbaum cashed out on 27,280,883 shares for a total of $177,508,500.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PARDES BIOSCIENCES, INC. No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-99.99%
-16.81M
1K
Aug 31
Form 4
0
0
Jun 1
Form 4
+9.68%
773.95K
$1.50
$1,160,928.00
8.77M
Apr 5
Form 4
+6.04%
773.95K
$1.50
$1,160,928.00
13.58M
Apr 5
Form 4
+5.24%
637.42K
$0.85
$541,807.00
12.81M
Dec 1
Form 4
0
0
Jun 8
Form 4/A
0
0
Dec 23
Form 4/A
4.94M
4.94M
Dec 23
Form 4
13.63M
$10.00
$10,000,000.00
13.63M
Dec 23
Form 4
325K
$10.00
$3,250,000.00
325K
Dec 22
Form 4
602.5K
$10.00
$6,025,000.00
602.5K
Feb 19
Form 3
0
0
No matching records found

Intellia Therapeutics, Inc. (NTLA) Snapshot price: $26.11

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

10x Genomics, Inc. (TXG) Snapshot price: $46.45

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+8.94%
480.2K
$80.13
-$116,188,500.00
5.85M
May 12 - May 13
Form 4
+59.35%
2M
5.37M
May 6
Form 4
+14.67%
392.26K
3.07M
Apr 22 - Apr 23
Form 4
+13.29%
387.81K
3.3M
Apr 13 - Apr 14
Form 4
+1,157.66%
2.17M
2.36M
Mar 24
Form 4
+15.36%
559K
$59.00
-$44,250,000.00
4.2M
Mar 4 - Mar 18
Form 4
187.5K
$39.00
$7,312,500.00
187.5K
Sep 12 - Sep 16
Form 3
0
0
No matching records found

Aclaris Therapeutics, Inc. (ACRS) Snapshot price: $1.13

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-99.58%
-1.95M
8.28K
Nov 1
Form 3
0
0
No matching records found

Quantum-Si Inc (QSI) Snapshot price: $1.6

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
8.42M
$7.82
$12,500,348.13
8.42M
Jun 10 - Jun 11
Form 3
0
0
No matching records found